ライフサイエンスコーパス: stromal cell

1 well as in vitro-cultured human mesenchymal stromal cells.

2 first model of two types of DS iPSC-derived stromal cells.

3 ent expression into adulthood in mesenchymal stromal cells.

4 extracellular matrix by tendon and ligament stromal cells.

5 , endothelial cells, perivascular cells, and stromal cells.

6 ng osteoblast differentiation of bone marrow stromal cells.

7 buted to viral control in non-hematological, stromal cells.

8 mphatics, nerves, and subsets of specialized stromal cells.

9 ogeneic bone marrow-derived mesenchymal stem/stromal cells.

10 on of matrisome proteins in cancer cells and stromal cells.

11 enetically abnormal cancer cells with normal stromal cells.

12 artially dependent on receptor expression on stromal cells.

13 the proinflammatory phenotype of tendon tear stromal cells.

14 gnaling, suggesting involvement of nonimmune stromal cells.

15 essed on ROR1(+) tumor cells but not ROR1(+) stromal cells.

16 by tumors and promote tumor growth as tumor stromal cells.

17 ialized microenvironments created by sessile stromal cells.

18 ells in short-term cultures with and without stromal cells.

19 y ill patients treated with mesenchymal stem/stromal cells.

20 otumoral p16INK4a-dependent senescence in BM stromal cells.

21 and 236 up-regulated in KC-affected corneal stromal cells.

22 ls from neighboring nonmalignant bone marrow stromal cells.

23 ay positively correlated with the density of stromal cells.

24 ls without altering viability of bone marrow stromal cells.

25 se contacts with SCF-expressing perivascular stromal cells.

26 of the mediators produced by tendon-derived stromal cells, 15-epi-Lipoxin A(4) (15-epi-LXA(4)) or ma

27 We hypothesized that lung stromal cells activate pathological gene expression prog

28 CXCL4 ameliorates the MPN phenotype, reduces stromal cell activation and BM fibrosis, and decreases t

29 ith well-characterized biological effects on stromal cell activation, angiogenesis, and osteoclastoge

30 ation of BAs from human adipose-derived stem/stromal cells (ADSCs) in serum-free medium with efficien

31 rast, Hh-pathway activation in epithelial or stromal cells alone resulted in tumor formation or strom

32 In the context of bone marrow derived stromal cell and adipose derived stromal cell differenti

33 n attachment to and invasion of the decidual stromal cells and ability to lyse red blood cells.

34 fferentiation stages of H3.3 WT and H3.3 MUT stromal cells and add to H3.3-G34W-associated changes.

35 cadian machinery in immortalized bone marrow stromal cells and adipose derived stromal cells highligh

36 plications for genomic instability of cancer stromal cells and beyond.

37 ed CXCL12 expression in vivo and in vitro in stromal cells and CXCL12 increased stromal migration and

38 e marrow, in which leptin receptor(+) (LepR) stromal cells and endothelial cells synthesize factors r

39 Stromal cells and especially cancer-associated fibroblas

40 ells and endothelial cells in the context of stromal cells and growth factors.

41 ting complex interactions among tumor cells, stromal cells and immune infiltrates in the TME.

42 ensive cell projections branched to adjacent stromal cells and interacted with the basal lamina and c

43 M signals through p66Shc to induce Cxcl12 in stromal cells and retain HSPC.

44 ndings support the immunosuppressive role of stromal cells and T-cell exclusion within the vicinity o

45 state cancer cell growth by interacting with stromal cells and through ECM remodeling and endocrine/p

46 e analyzed to estimate content of immune and stromal cells and to define disease-associated gene sign

47 In untreated tumors, we find expected stromal cells and tumor-derived cells showing either a s

48 t our approach identifies the proportions of stromal cells and tumor-infiltrating immune cells, as we

49 ts required simultaneous engagement with OP9 stromal cells and were also stage-specific, with NOTCH1

50 Of those, mesenchymal stromal cells and, to a lesser extent, regulatory T cell

51 human hMSCs (bone marrow-derived mesenchymal stromal cells) and cKit(+) cardiac cells.

52 of ECM deposition, sustained Ki67 levels in stromal cells, and a persistent M2 macrophage response t

53 e production of inflammatory factors from BM stromal cells, and disruption of the PC-stromal cell cir

54 arises within incipient tumour cells versus stromal cells, and how these roles can change in differe

55 acting cell types, particularly endothelium, stromal cells, and innate leukocytes.

56 ncluding myogenic stem and progenitor cells, stromal cells, and pluripotent stem cells, have been inv

57 izes its compositional pattern of immune and stromal cells, and reveals S100A8/A9 to be a novel bioma

58 ly increase in mouse and human decidualizing stromal cells, and that neutralization of CB1 signaling

59 r functionally specialized subpopulations of stromal cells, and, most notably, two distinct populatio

60 n of 6 AngII signature proteins (bone marrow stromal cell antigen 1, glutamine synthetase [GLNA], lam

61 with its IFN-I-regulated ligand, bone marrow stromal cell antigen 2 (BST2) plays a key role in contro

62 genes (ISGs), such as ISG15 and bone marrow stromal cell antigen 2 (BST2).

63 ed significant downregulation of bone marrow stromal cell antigen-2 (BST2), a potential therapeutic t

64 Thus, both FLC epithelial and stromal cells appear to arise from DNAJB1-PRKACA fusion

65 in gel in which CD34(+) cells and BM-derived stromal cells are co-cultured, a parallel channel lined

66 lighting a unique mechanism by which dormant stromal cells are enlisted for skeletal regeneration.

67 Indeed, when preimplantation endometrial stromal cells are exposed to hypoxic conditions in vitro

68 owever, lineage relationships within cardiac stromal cells are poorly defined.

69 of mice expressing PDGFRbeta(D849V) in their stromal cells as a preclinical model of breast cancer-as

70 ing, we identified Ccl19-Cre(+) fibroblastic stromal cells as critical sources of Delta-like ligands

71 e adipocytes, highlighting the importance of stromal cells as innate immune effectors.

72 Here we use bone marrow stromal cells as sensors of age-associated changes to th

73 homeostasis, focusing on the involvement of stromal cells as these cells perform anchoring and nurtu

74 that disrupt ER homeostasis in malignant and stromal cells, as well as infiltrating leukocytes.

75 Emerging evidence indicates that adipose stromal cells (ASC) are recruited to enhance cancer deve

76 d animal model studies indicate that adipose stromal cells (ASC), the progenitors of adipocytes, are

77 tes myofibroblast differentiation of adipose stromal cells (ASCs) independent of bulk stiffness.

78 most intimately associated with adventitial stromal cells (ASCs), a mesenchymal fibroblast-like subs

79 IL-15, a stromal cell-associated cytokine found within spleens an

80 (Hif2alpha), which is induced in subluminal stromal cells at the time of implantation, plays a cruci

81 Here, we construct a stromal cell atlas of human fibrosis at single cell reso

82 epithelial stem or progenitor cells whereas stromal cell-autonomous canonical Wnt/beta-catenin signa

83 eposited at E13 from the presumptive corneal stromal cells, become organised into fibril bundles orth

84 With implantation, mouse stromal cells begin to transform into epithelial-like ce

85 ent exosome populations mediate diversity in stromal cell behavior.

86 but hallmark features include immune cells, stromal cells, blood vessels, and extracellular matrix.

87 Bone marrow-Multipotential stromal cells (BM-MSCs) are increasingly used to treat c

88 injection of bone marrow-derived mesenchymal stromal cells (BM-MSCs) or adipose tissue-derived MSCs (

89 nt modulator of bone marrow mesenchymal stem/stromal cell (BMSC) chondrogenesis.

90 ces (ECM) alone or together with bone marrow stromal cells (BMSC).

91 re with bone marrow-derived mesenchymal stem/stromal cells (BMSC).

92 Bone marrow stromal cells (BMSCs) are versatile mesenchymal cell pop

93 se M2 (PKM2) from PCa cells into bone marrow stromal cells (BMSCs) as a novel mechanism through which

94 Metabolic programming of bone marrow stromal cells (BMSCs) could influence the function of pr

95 When bone marrow stromal cells (BMSCs) from WT and Col6alpha2-KO mice wer

96 mitochondrial transfer from the bone marrow stromal cells (BMSCs) to HSCs through a reactive oxygen

97 al cell types, including bone marrow-derived stromal cells (BMSCs), display tissue-specific responses

98 ghtened osteogenic commitment of bone marrow stromal cells (BMSCs).

99 uggests that, together with nonhematopoietic stromal cells, bone marrow (BM) immune cells with unique

100 matrix (ECM) into which pericytes and other stromal cells can be introduced to recapitulate tissue-s

101 at carry signaling molecules, from senescent stromal cells can promote tumorigenesis and multidrug re

102 , we found that Gli1(+) PMCs are a subset of stromal cells characterized by active hedgehog signaling

103 m BM stromal cells, and disruption of the PC-stromal cell circuitry with inhibitors of the cytokines

104 arget of mouse and human cardiac mesenchymal stromal cells (cMSC) with progenitor-like features.

105 to the omentum by illustrating how different stromal cells concertedly contribute to the development

106 l cells alone resulted in tumor formation or stromal cell condensation respectively, without inductio

107 c erythroid progenitor cells and mesenchymal stromal cells contribute directly and indirectly to both

108 Tumor and stromal cells cooperated in forming niches; stromal cell

109 t individual matrisome proteins derived from stromal cells correlate with either long or short patien

110 Immune and stromal cells could also be distinguished by their metab

111 Mineralization of WT bone marrow stromal cells cultured with conditioned medium from Hdac

112 Because endometrial stromal cell decidualization is also critical to human r

113 ne receptivity, blastocyst implantation, and stromal cell decidualization, which are key events in pr

114 /-) mice is neutrophil-intrinsic rather than stromal cell-dependent.

115 we focus on how tumour and tumour-associated stromal cells deposit, biochemically and biophysically m

116 Furthermore, we introduce a mesenchymal stromal cell derived from human olfactory tissue, which

117 Primary mammary adipose stromal cells derived from women with obesity displayed

118 ic vascular endothelial growth factor (VEGF)-stromal cell-derived factor 1 (sdf1) signaling, leading

119 ng osteogenic differentiation and decreasing stromal cell-derived factor 1 in the bone marrow that fa

120 cyte growth factor, placental growth factor, stromal cell-derived factor 1alpha, and basic fibroblast

121 marrow by vascular endothelial growth factor-stromal cell-derived factor-1 (VEGF-sdf-1) signaling pro

122 dentify a niche in the neonatal airway where stromal cell-derived insulin-like growth factor 1 (IGF1)

123 CTB EVs increased decidual stromal cell (dESF) transcription and secretion of NF-ka

124 Mesenchymal stromal cells did not alter clinical score or survival r

125 lion cells/kg of allogeneic mesenchymal stem/stromal cells did not exacerbate elevated cytokine level

126 In vitro, bone marrow stromal cells differentiated into adipocytes and, treate

127 row derived stromal cell and adipose derived stromal cell differentiation, miRNAs are established reg

128 nical Wnt ligand Wnt5a, secreted by proximal stromal cells, directly inhibits proliefration of prosta

129 ed telomerase-immortalized human endometrial stromal cells (dT-HESCs) following infection with GBS st

130 ine neurotransmitters and dietary amines, in stromal cells elevates production of reactive oxygen spe

131 Engraftment of engineered mesenchymal stromal cells (eMSCs) together with CD34(+) HSPCs create

132 Coculture with adipose stromal cells enabled the metabolism of testosterone (T)

133 the tumour and/or the associated immune and stromal cells enables the dissection of tumour heterogen

134 We find that mesenchymal stromal cells engineered to express membrane-bound FLT3L

135 Targeting epicardium-derived stromal cells (EpiSC) by specific ligands might enable t

136 is in DeltaNC16A mice is through bone marrow stromal cells evidenced by bone marrow transplantation.

137 nt cell tumors of bone where patient-derived stromal cells exhibit gene expression profiles associate

138 MCF7-derived ducts cocultured with obese stromal cells exhibited higher maximal aromatization-ind

139 ibition of NOTCH1 activity suppresses cancer/stromal cells expansion.

140 Both secretory epithelial and stromal cells expressed Ki67 that was detectable at day

141 retion of ECM protein fibronectin (FN) by BM stromal cells from PMF patients correlates with fibrosis

142 tained intracellular pH influence cancer and stromal cell function, their mutual interplay, and their

143 the impact of in vitro culture conditions on stromal cell gene expression and proliferation, showing

144 We show that in patient-derived stromal cells H3.3-G34W is incorporated into the chromat

145 co-cultured with human adipose-derived stem/stromal cells (hASCs).

146 Human bone marrow stromal cell (HBMSC) and HUVEC spheroids were implanted

147 one marrow stromal cells and adipose derived stromal cells highlighting its importance in iBMSC and A

148 study, human bone marrow-derived mesenchymal stromal cell (hMSCs) was used as a viral replication-per

149 Human mesenchymal stromal cells (hMSCs) are a promising source for enginee

150 indicated Pfn1 positivity in both tumor and stromal cells; however, the vast majority of ccRCC tumor

151 to primary tumor sites and either human bone stromal cells (HS-5) in a hydrogel or human-derived bone

152 during both immortalized bone marrow derived stromal cell (iBMSC) as well as primary patient adipose

153 of IL-1beta treated AT and AR tendon-derived stromal cells in 15-epi-LXA(4) or MaR1 reduced proinflam

154 K/STAT activation in both megakaryocytes and stromal cells in 3 murine PMF models.

155 p sinuses, T cells latched onto perivascular stromal cells in a manner that was independent of the ch

156 tment and activity of immune cells and other stromal cells in breast cancer remain poorly understood.

157 Deletion of Islr in stromal cells in mice markedly impaired intestinal regen

158 atic aberrations, infiltration of immune and stromal cells in proportions correlated with tumor stage

159 that show some resemblance to the reticular stromal cells in secondary lymphoid organs.

160 trial evaluating allogeneic mesenchymal stem/stromal cells in septic shock patients.

161 n cancer cells and various cancer-associated stromal cells in the metastatic tumor microenvironment w

162 The functional role of human derived stromal cells in the tumor microenviornment of CNS metas

163 ible factors that can affect cancer cells or stromal cells in the tumour microenvironment.

164 e phenotypic and functional heterogeneity of stromal cells in tumors.

165 lymphoid organs are aggregates of immune and stromal cells including high endothelial venules and lym

166 inhibitors inhibit the bone microenvironment stromal cells including osteoblasts and osteoclasts, and

167 d extracellular circuits either in cancer or stromal cells, including immune cells, endothelial cells

168 plex mixture of tumor cells and nonmalignant stromal cells, including neurons, astrocytes, microglia,

169 r, an oncogenic transcription factor ETS1 in stromal cells induces expression of a secreted protein I

170 og (Hh) signaling in adjacent epithelial and stromal cells induces new HFs in adult, unwounded dorsal

171 Cationic interfaces elicit stromal cell infiltration, peripherally derived inflamma

172 at study baseline prior to mesenchymal stem/stromal cell infusion (0 hr), 1 hour, 4 hours, 12 hours,

173 4 hours, and 72 hours after mesenchymal stem/stromal cell infusion/trial enrollment.

174 al irregularity and complexity of the cancer-stromal cell interface significantly increased in tumor

175 f a population of podoplanin (pdpn)-positive stromal cells into a network of immunofibroblasts that a

176 The transition of synovial stromal cells into autoaggressive effector cells convert

177 iferation and differentiation of endometrial stromal cells into decidual cells, is required for impla

178 ion of the ligand prolactin by adjacent lung stromal cells is induced by tumor cell production of the

179 last growth factor 2 (FGF2) from bone marrow stromal cells is secreted in exosomes, which are subsequ

180 ing of conditioned media from adipocytes and stromal cells isolated from human AT, have led to the id

181 ve lipid mediator profiles of tendon-derived stromal cells isolated from patients with Achilles tendi

182 surgery, mice were treated with mesenchymal stromal cells IV (1 x 10 cells in 0.05 mL of saline/mous

183 so supports the concept of plasticity of the stromal cell landscape in tumors, laying the foundation

184 d into specialized niche areas by lymph node stromal cells (LN SCs).

185 Lymph node stromal cells (LNSC) are essential for providing and mai

186 Lymph node stromal cells (LNSCs) regulate immunity through construc

187 , are mesenchymal and endothelial lymph node stromal cells (LNSCs).

188 ion in human adult lung-resident mesenchymal stromal cells (LR-MSCs) remain to be elucidated.

189 upon damage and is expressed in mesenchymal stromal cells, macrophages, and Paneth cells.

190 ed tumor microenvironment stiffness leads to stromal cell-mediated TGF-beta family signaling relying

191 Mesenchymal stromal cells mitigated these cognitive and behavioral a

192 e the developmental origin of mesenchymal LN stromal cells (mLNSCs) to a previously undescribed embry

193 orin (ASPN) as a novel, secreted mesenchymal stromal cell (MSC) factor in the tumor microenvironment

194 Rationale: Mesenchymal stromal cell (MSC) therapy is a promising intervention f

195 We report that BM mesenchymal stromal cells (MSC) undergo massive damage to their mito

196 precursors, abundantly available mesenchymal stromal cells (MSC) were reprogrammed into induced endot

197 which induces PGE2 synthesis in mesenchymal stromal cells (MSC), in turn activating beta-catenin sig

198 tion and migration of endogenous mesenchymal stromal cells (MSCs) are critical for bone regeneration.

199 Mesenchymal stem/stromal cells (MSCs) are multipotent cells that are emer

200 Multipotent mesenchymal stromal cells (MSCs) are required for skeletal formation

201 Multipotent Mesenchymal Stem/Stromal Cells (MSCs) are widely used in cellular therapy

202 eutic potential of donor-derived mesenchymal stromal cells (MSCs) has been investigated in diverse di

203 tation of mesenchymal stem cells/multipotent stromal cells (MSCs) has been proposed to augment the re

204 ade, the clinical application of mesenchymal stromal cells (MSCs) has generated growing enthusiasm as

205 Multipotential stromal cells (MSCs) have a crucial role in joint repair

206 Bone marrow mesenchymal stromal cells (MSCs) have been studied for decades as po

207 Mesenchymal stromal cells (MSCs) have protolerogenic effects in rena

208 factors by Nestin-GFP(+) mesenchymal-derived stromal cells (MSCs) is downregulated upon culture, sugg

209 Mesenchymal stem/stromal cells (MSCs) provide an attractive cell source f

210 roaches aim to infuse allogeneic mesenchymal stromal cells (MSCs) to provide a more generalized treat

211 r studies that have transplanted mesenchymal stromal cells (MSCs) without co-administration of a hema

212 Here, we show that Gli1(+) mesenchymal stromal cells (MSCs), previously shown to contribute to

213 roperties of bone marrow-derived mesenchymal stromal cells (MSCs)-seeded bone microparticles compared

214 cell populations, primarily mesenchymal stem/stromal cells (MSCs).

215 ing AML cells, normal HSPCs, and mesenchymal stromal cells (MSCs).

216 osteoblastic differentiation of mesenchymal stromal cells (MSCs).

217 eated with exosomes derived from mesenchymal stromal cells (MSCs).

218 leukin (IL)-33 produced by local mesenchymal stromal cells (mSCs).

219 l therapy with human bone marrow mesenchymal stromal cells (MSCs).

220 in the abundance of perivascular mesenchymal stromal cells (MSCs)/osteoprogenitors and osteoblasts fo

221 ring vessel-forming cells (human mesenchymal stromal cells [MSCs] and endothelial colony-forming cell

222 vational cohort received no mesenchymal stem/stromal cells (n = 21).

223 contains chondrocytes (OAC) and mesenchymal stromal cells (OA-MSC).

224 The neoplastic stromal cells of giant cell tumor of bone (GCTB) carry a

225 ntains the bile duct, which is surrounded by stromal cells often called portal fibroblasts.

226 and proliferation of corneal epithelial and stromal cells on their surface.

227 mors tend to be Pfn1-positive selectively in stromal cells only.

228 in which the GC receptor (GR) was deleted in stromal cells/osteoblasts.

229 ricyte, neuron-astrocyte, and diverse cancer-stromal cell pairs.

230 ) as well as primary patient adipose derived stromal cell (PASC) adipogenesis.

231 inducing TGF-beta activation on mesenchymal stromal cells (pericytes), Amphiregulin induced their di

232 ancer, interactions between cancer cells and stromal cells play a major role in nearly every step of

233 horionic villus-derived placenta mesenchymal stromal cells (PMSCs) as a potential treatment for spina

234 differentiation of a unique IL-33-producing stromal cell population specific to the male VAT, which

235 ght the functional contributions of distinct stromal cell populations during LN development in mainta

236 progression; however, genetic alterations in stromal cell populations remain largely unexplored.

237 ent genetic alterations in colorectal cancer stromal cell populations.

238 ompared with the bulk matrix, mostly made by stromal cells, precise interventions targeting cancer ce

239 Infected splenic stromal cells produced IFN-I in a cGAS-STING-dependent a

240 stromal cells cooperated in forming niches; stromal cells produced predominantly core, structural EC

241 lactate secretion, and abrogates endometrial stromal cell proliferation in a coculture model.

242 More specifically, RAGE expressed on stromal cells, rather than hematopoietic cells, is criti

243 ccharide, conditioned media from mesenchymal stromal cells reduced astrogliosis, interleukin-1beta, a

244 Depletion of Wt1(+) stromal cells reduced the frequency of GATA6(+) macropha

245 reveal how omental stromal cells regulate neutrophil trafficking to control

246 Co-culture models demonstrated these stromal cell responses were mediated by tumor-derived CC

247 A sequencing and spatial analysis of omental stromal cells revealed that the surface of FALCs were co

248 In response to tissue injury, stromal cells secrete extracellular matrix (ECM) compone

249 thin the BM microenvironment and that the BM stromal cell senescence is driven by p16INK4a expression

250 Stromal cells serve as critical components of the hemato

251 Moreover, the expression of stromal cell-specific ISLR and ETS1 significantly increa

252 These data define cSCC tumor and stromal cell subpopulations, the spatial niches where th

253 ve skin cell atlas, including epithelial and stromal cells such as fibroblasts, vascular, and immune

254 Such dual engagement of cancer and stromal cells suggests crosstalk mediated by EGFL6 in th

255 terregulate inflammatory processes in tendon stromal cells, supporting the role of these molecules as

256 rsible damage to a population of tolerogenic stromal cells that display peripheral tissue-restricted

257 were induced by mesothelial and fibroblastic stromal cells that express the transcription factor Wilm

258 transcriptional responses in epithelial and stromal cells that interface with the luminal contents o

259 duced pANXA2 expression in tumour-associated stromal cells, the octapeptide preferentially binds to t

260 The p16INK4a-expressing senescent stromal cells then feed back to promote AML blast surviv

261 has investigated the effects of mesenchymal stromal cell therapy on the blood-brain barrier, astrocy

262 ho survived experimental sepsis, mesenchymal stromal cell therapy protected blood-brain barrier integ

263 actors orchestrate splenic hematopoietic and stromal cells to fuel metastasis.

264 helium ISLR-YAP signaling axis essential for stromal cells to modulate epithelial cell growth during

265 rs as well as interact with other immune and stromal cells to promote the complex and active process

266 thetic and sensory) interact with tumour and stromal cells to promote the initiation and progression

267 major impact on the capacity of endometrial stromal cells to recruit CD8 cells.

268 nd provide a rationale for targeting MAOA in stromal cells to treat PC.

269 Tumor and stromal cells together create distinct ECM niches in bre

270 In addition, tumor and stromal cells together created distinct niches in each t

271 demonstrate in multiple myeloma, bone marrow stromal cells transfer mitochondria to myeloma cells to

272 Stromal cells transform into epithelial-like cells to fo

273 al biological mechanisms of mesenchymal stem/stromal cell treatment and support further investigation

274 y and biological effects of mesenchymal stem/stromal cell treatment, as no previous study has conduct

275 In human PSC, inflammatory and stromal cells trigger PBG activation through the up-regu

276 actions between malignant cells and a single stromal cell type, often along a single pathway.

277 c milieu characterises functionally distinct stromal cell types and states, including a subset of imm

278 between ovarian cancer cells and surrounding stromal cell types in the adipose-rich metastatic microe

279 oid cells and T cells were the most abundant stromal cell types in tumors and adjacent lung tissues.

280 As many stromal cell types, including bone marrow-derived stroma

281 les to shed light on the emergence of thymic stromal cell types, the first developing T lymphocytes,

282 icroenvironment of interacting malignant and stromal cell types.

283 h differing capacities for interactions with stromal cell types.

284 croenvironments (TMEs) together with various stromal cell types.

285 r progression and metastasis, both tumor and stromal cells undergo rapid metabolic adaptations.

286 ritic cells, follicular dendritic cells, and stromal cells, usually located surrounding airways or bl

287 tiousness/propagation in human term decidual stromal cells versus trophoblasts.

288 esis to mobilopathy by inducing Cxcl12 in BM stromal cells via nonmitochondrial p66Shc.

289 nd, importantly, subtypes of VAT mesenchymal stromal cells (VmSCs) that are either immunomodulators o

290 at white adipose tissue-resident multipotent stromal cells (WAT-MSCs) can act as a reservoir for IL-3

291 Stromal cells were cultured from human corneas (HCSC) an

292 Ventral prostate epithelial and stromal cells were isolated from F3 generation 20-day ol

293 Tumor-infiltrating stromal cells, which include macrophages/microglia, cont

294 IL11 acts on bone-marrow-derived mesenchymal stromal cells, which induce pro-tumorigenic and pro-meta

295 ELF-E subunits in cultured human endometrial stromal cells, which inhibited decidualization, as refle

296 er, the spatial configurations of immune and stromal cells, which may shed light on the evolution of

297 dynamic interaction exists between tumor and stromal cells, which results in the promotion of thyroid

298 L blasts induce a senescent phenotype in the stromal cells within the BM microenvironment and that th

299 f tumors of diverse histotypes and increased stromal cells within the tumor microenvironment.

300 prises different, heterogenous compartments; stromal cells within those compartments might have uniqu